Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes

• Published in: The Journal of biological chemistry Vol. 295; no. 49; pp. 16773 - 16784
• Main Authors: Pakharukova, Natalia, Masoudi, Ali, Pani, Biswaranjan, Staus, Dean P., Lefkowitz, Robert J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 04-12-2020; American Society for Biochemistry and Molecular Biology
• Subjects: Allosteric Regulation; arrestin; beta-Arrestin 1 - chemistry; beta-Arrestin 1 - genetics; beta-Arrestin 1 - metabolism; Enzyme Activation; G protein-coupled receptors; GPCR; Humans; Kinetics; Mutagenesis, Site-Directed; Nanostructures - chemistry; Peptides - chemical synthesis; Peptides - chemistry; Phosphorylation; Protein Binding; Proto-Oncogene Mas; Receptor, Muscarinic M2 - chemistry; Receptor, Muscarinic M2 - metabolism; Receptors, Adrenergic, beta-2 - chemistry; Receptors, Adrenergic, beta-2 - metabolism; Receptors, Vasopressin - chemistry; Receptors, Vasopressin - metabolism; Recombinant Proteins - biosynthesis; Recombinant Proteins - chemistry; Recombinant Proteins - isolation & purification; Signal Transduction; Src; src Homology Domains; src-Family Kinases - chemistry; src-Family Kinases - metabolism; Substrate Specificity; GPCR; G protein-coupled receptors; allosteric regulation; arrestin; Src; signal transduction
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.RA120.015400

G protein–coupled receptors (GPCRs) initiate signaling cascades via G-proteins and beta-arrestins (βarr). βarr-dependent actions begin with recruitment of βarr to the phosphorylated receptor tail and are followed by engagement with the receptor core. βarrs are known to act as adaptor proteins binding receptors and various effectors, but it is unclear whether in addition to the scaffolding role βarrs can allosterically activate their downstream targets. Here we demonstrate the direct allosteric activation of proto-oncogene kinase Src by GPCR–βarr complexes in vitro and establish the conformational basis of the activation. Whereas free βarr1 had no effect on Src activity, βarr1 in complex with M2 muscarinic or β2-adrenergic receptors reconstituted in lipid nanodiscs activate Src by reducing the lag phase in Src autophosphorylation. Interestingly, receptor–βarr1 complexes formed with a βarr1 mutant, in which the finger-loop, required to interact with the receptor core, has been deleted, fully retain the ability to activate Src. Similarly, βarr1 in complex with only a phosphorylated C-terminal tail of the vasopressin 2 receptor activates Src as efficiently as GPCR–βarr complexes. In contrast, βarr1 and chimeric M2 receptor with nonphosphorylated C-terminal tail failed to activate Src. Taken together, these data demonstrate that the phosphorylated GPCR tail interaction with βarr1 is necessary and sufficient to empower it to allosterically activate Src. Our findings may have implications for understanding more broadly the mechanisms of allosteric activation of downstream targets by βarrs.